| LC | Langerhans cells |
| UV | Ultraviolet radiation |
| Treg | Regulatory T cells |
| AD | Atopic dermatitis |
| TNF-α | Tumor necrosis factor-α |
| IL-6 | Interleukin-6 |
| COX-2 | Cyclooxygenase-2 |
| Src | Non-receptor tyrosine kinase |
| CPD | Cyclobutene pyrimidine dimers |
| NER | Nucleotide excision repair |
| MMP-1 | Metalloproteinases-1 |
| MAPK | Mitogen-activated protein kinase |
| AP-1 | Activator protein 1 |
| nHDF | Normal Human Dermal Fibroblasts |
| IgE | Immunoglobulin E |
| IFN-γ | Interferon-gamma |
| PiCl | Picrylchloride |
| STAT6 | Signal transducers and activators of transcription 6 |
| IL-4 | Interleukin-4 |
| IL-31 | Interleukin-31 |
| HMC-1 | Human mast cells |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| IKK | Inhibitor of NF-κB kinase |
| IκB | Inhibitor of kappaB |
| JNK | c-Jun N-terminal kinase |
| ERK | Extracellular signal-regulated kinase |
| CCL26 | Eosinophil chemokine |
| IL-31RA | Interleukin-31 receptor A |
| ILC2 | Innate lymphoid cells-2 |
| CXCR3 | C-X-C Motif Chemokine Receptor 3 |
| TSLP | Thymic stromal lymphopoietin |
| CCL | C-C motif chemokine ligand |
| NK cells | Natural killer cells |
| OVA | Ovalbumin |
| T-bet | T-box protein expressed in T cells |
| IL-23 | Interleukin-23 |
| LPS | Lipopolysaccharide |
| TLR4 | Toll-like receptor 4 |
| TME | Tumor microenvironments |
| BCCs | Basal cell carcinomas |
| CMs | Cutaneous malignant melanomas |
| NMSC | Nonmelanocytic skin cancer |
| SCCs | Squamous cell carcinomas |
| TRAIL | TNF-related apoptosis-inducing ligand |
| mTOR | Mammalian target of rapamycin |
| HEKs | Human epidermal keratinocytes |
| COLO-16 | Skin cutaneous squamous cell carcinoma cell line |
| LC3 | Light chain 3 |
| TPA | 12-O-tetradecanoylphorbol-13-acetate |
| Bax | Bcl-2-associated X protein |
| PARP | Poly ADP-ribose polymerase |
| SOD | Superoxide dismutase |
| CAT | Catalase |
| GSH-Px | Glutathione peroxidase |